Vir Biotechnology, Inc.

Halal Rating :
See Details
Last Price $8.92 Last updated:
Market Cap $1.41b
7D Change -2.83%
1 Year Change -2.83%

Company Overview

  • Commercial Services
  • Miscellaneous Commercial Services
  • Health Technology
  • Biotechnology
Exchange NASDAQ
Next Earnings Date Feb. 22, 2024

Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. The company is headquartered in San Francisco, California.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
March 31, 2024 $56.38m $136.46m $21.28m - 37.75% 0.00%
Dec. 31, 2023 $16.79m $155.37m $20.74m $239000.0 123.52% 0.15%
Sept. 30, 2023 $2.64m $189.37m $21.93m - 831.03% 0.00%

Company Impact

Help us evaluate Vir Biotechnology, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Justification for our Halal Rating

Recent News & Updates